JP2023517295A5 - - Google Patents
Info
- Publication number
- JP2023517295A5 JP2023517295A5 JP2022552932A JP2022552932A JP2023517295A5 JP 2023517295 A5 JP2023517295 A5 JP 2023517295A5 JP 2022552932 A JP2022552932 A JP 2022552932A JP 2022552932 A JP2022552932 A JP 2022552932A JP 2023517295 A5 JP2023517295 A5 JP 2023517295A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- administered
- stereoisomer
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382152.5 | 2020-03-02 | ||
| EP20382152 | 2020-03-02 | ||
| EP20382192.1 | 2020-03-13 | ||
| EP20382192 | 2020-03-13 | ||
| EP20382266 | 2020-04-02 | ||
| EP20382266.3 | 2020-04-02 | ||
| EP20382339 | 2020-04-27 | ||
| EP20382339.8 | 2020-04-27 | ||
| EP20382816.5 | 2020-09-16 | ||
| EP20382816 | 2020-09-16 | ||
| EP20382815.7 | 2020-09-16 | ||
| EP20382815 | 2020-09-16 | ||
| PCT/EP2021/055137 WO2021175826A1 (en) | 2020-03-02 | 2021-03-02 | Compounds for use in the treatment of coronavirus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517295A JP2023517295A (ja) | 2023-04-25 |
| JP2023517295A5 true JP2023517295A5 (https=) | 2024-03-12 |
Family
ID=74797953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552932A Pending JP2023517295A (ja) | 2020-03-02 | 2021-03-02 | コロナウイルス感染の処置に使用する化合物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20230158102A1 (https=) |
| EP (1) | EP4114436A1 (https=) |
| JP (1) | JP2023517295A (https=) |
| KR (1) | KR20220151181A (https=) |
| CN (1) | CN115666615A (https=) |
| AU (1) | AU2021232534A1 (https=) |
| BR (1) | BR112022017008A2 (https=) |
| CA (1) | CA3169791A1 (https=) |
| CL (1) | CL2022002398A1 (https=) |
| CO (1) | CO2022014115A2 (https=) |
| IL (1) | IL296066A (https=) |
| MX (1) | MX2022010922A (https=) |
| PE (1) | PE20231069A1 (https=) |
| PY (1) | PY2117315A (https=) |
| TW (1) | TW202144380A (https=) |
| UY (1) | UY39108A (https=) |
| WO (1) | WO2021175826A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021231521A1 (en) * | 2020-03-02 | 2022-10-06 | Pharma Mar, S.A. | PLD for use in combination in the treatment of coronavirus |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8922026D0 (en) * | 1989-09-29 | 1989-11-15 | Pharma Mar Sa | Novel anti-viral and cytotoxic agent |
| GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| CA2405779A1 (en) | 2000-04-07 | 2001-10-18 | The Trustees Of The University Of Pennsylvania | Tamandarin and didemnin analogs and methods of making and using them |
| UA76718C2 (uk) | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
| JP2006523214A (ja) | 2003-03-21 | 2006-10-12 | ジユーリー，マデレーン・エム | タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法 |
| US7605135B2 (en) * | 2003-11-10 | 2009-10-20 | The University Of Hong Kong | Baicalin as a treatment for SARS infection |
| JP2012512839A (ja) * | 2008-12-19 | 2012-06-07 | ファルマ、マール、ソシエダード、アノニマ | 抗腫瘍性化合物 |
| WO2011020913A2 (en) | 2009-08-21 | 2011-02-24 | Pharma Mar, S.A. | Cyclodepsipeptide antiviral compounds |
| CN115461067A (zh) * | 2020-03-02 | 2022-12-09 | 法马马有限公司 | 用于炎症的化合物 |
-
2021
- 2021-03-02 US US17/908,524 patent/US20230158102A1/en active Pending
- 2021-03-02 CA CA3169791A patent/CA3169791A1/en active Pending
- 2021-03-02 TW TW110107291A patent/TW202144380A/zh unknown
- 2021-03-02 CN CN202180018709.2A patent/CN115666615A/zh active Pending
- 2021-03-02 KR KR1020227034222A patent/KR20220151181A/ko active Pending
- 2021-03-02 PE PE2022001871A patent/PE20231069A1/es unknown
- 2021-03-02 JP JP2022552932A patent/JP2023517295A/ja active Pending
- 2021-03-02 BR BR112022017008A patent/BR112022017008A2/pt unknown
- 2021-03-02 AU AU2021232534A patent/AU2021232534A1/en active Pending
- 2021-03-02 WO PCT/EP2021/055137 patent/WO2021175826A1/en not_active Ceased
- 2021-03-02 UY UY0001039108A patent/UY39108A/es unknown
- 2021-03-02 PY PY202102117315A patent/PY2117315A/es unknown
- 2021-03-02 MX MX2022010922A patent/MX2022010922A/es unknown
- 2021-03-02 IL IL296066A patent/IL296066A/en unknown
- 2021-03-02 EP EP21708649.5A patent/EP4114436A1/en active Pending
-
2022
- 2022-09-02 CL CL2022002398A patent/CL2022002398A1/es unknown
- 2022-09-30 CO CONC2022/0014115A patent/CO2022014115A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1093760C (zh) | 咔唑化合物在制备治疗充血性心力衰竭的药物中的应用 | |
| JP2023517535A5 (https=) | ||
| WO2011028794A2 (en) | Treatment of huntington's disease with cycloserine and an nmda receptor antagonist | |
| McLoughlin et al. | Therapy of Helicobacter pylori | |
| TWI890229B (zh) | Glp-1受體非肽促效劑化合物之口服投藥 | |
| JP2024533756A5 (https=) | ||
| US20250082626A1 (en) | Tesofensine and metoprolol for treatment of hypertension | |
| JP2023517295A5 (https=) | ||
| JP2004525143A5 (https=) | ||
| JP2022549066A5 (https=) | ||
| JP2021004249A5 (https=) | ||
| US20260102370A1 (en) | Methods of treating obesity in responder and non-responder populations | |
| US11497747B2 (en) | Compositions and methods for treating lung injuries associated with SARS-CoV-2 infections | |
| Marques da Silva | Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan | |
| CN110325214A (zh) | 用于预防和治疗神经元损伤的低剂量药物组合 | |
| US20080113952A1 (en) | Combination Therapy For Treating Heart Disease | |
| TW201806599A (zh) | 用於快速開始抗抑鬱作用之給藥方案 | |
| CN115515594A (zh) | 高尿酸血症的治疗 | |
| CN114929229A (zh) | 用米立可兰治疗抗精神病药导致的体重增加的方法 | |
| Silva | Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan | |
| WO2019232740A1 (zh) | 一种用于防治糖尿病的药物组合物及其用途 | |
| WO2005063253A1 (ja) | アレルギー症状治療用医薬組成物 | |
| WO2017100324A1 (en) | Combination therapy for treating female hypoactive sexual desire disorders | |
| TW202611066A (zh) | Glp-1類似物的醫藥用途 | |
| Nouriel et al. | Pharmacology of serotonin antagonists |